nach oben

Medical Microbiology and Immunology

Erschienen in:

28.11.2019 | Original Investigation

Alternative pathway of complement activation has a beneficial role against Chandipura virus infection

verfasst von: Pooja Gupta, Anuradha S. Tripathy

Erschienen in: Medical Microbiology and Immunology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

The complement system is a critical component of both innate and adaptive immune responses. It has both protective and pathogenic roles in viral infections. There are no studies regarding the role of complement system in Chandipura virus (CHPV) infection. The current study has investigated the role of complement pathways in the in vitro neutralization of CHPV in Vero E6 cells. Using normal human serum (NHS), heat-inactivated serum (HIS), human serum deficient of complement factor, respective reconstituted serum, assays like in vitro neutralization, real-time PCR, and flow cytometry-based tissue culture-based limited dose assay (TC-LDA) were carried out for assessing the activation of different complement pathways. NHS from 9/10 donors showed complement dependent neutralization, reduction in viral load and decrease in percentage of CHPV-positive cells compared to their HIS counterparts. EGTA or EDTA pretreatment experiments indicated that CHPV neutralization proceeds through the alternative pathway of the complement activation. Our data showed a strong dependence on C3 for the in vitro neutralization of CHPV. Disparity in CHPV neutralization levels between factor B-deficient and reconstituted sera could be attributed to amplification loop/“tick-over” mechanism. Assays using C3, C5, and C8 deficient sera indicated that complement-mediated CHPV neutralization and suppression of CHPV infectivity are primarily through C3 and C5, and not dependent on downstream complement factor C8. With no specific anti-viral treatment/vaccine against Chandipura, the current data, elucidating role of human complement system in the neutralization of CHPV, may help in designing effective therapeutics.

Bhatt PN, Rodrigues FM (1967) Chandipura: a new arbovirus isolated in India from patients with febrile illness. Indian J Med Res 55:1295–1305PubMed

Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA, Thakare JP, Jadi RS, Rao KA, Mishra AC (2004) A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus. Lancet 364:869–874PubMed

Tandale BV, Tikute SS, Arankalle VA, Sathe PS, Joshi MV, Ranadive SN, Kanojia PC, Eshwarachary D, Kumarswamy M, Mishra AC (2004) Chandipura virus: a major cause of acute encephalitis in children in north Telangana, Andhra Pradesh, India. J Med Virol 80:118–124

Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, Mahadev PV, Mishra AC (2005) An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat State, India. Am J Trop Med Hyg 73:566–570PubMed

Gurav YK, Tandale BV, Jadi RS, Gunjikar RS, Tikute SS, Jamgaonkar AV (2010) Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. Indian J Med Res 132:395–399PubMed

Dwibedi B, Sabat J, Hazra RK, Kumar A, Dinesh DS, Kar SK (2015) Chandipura virus infection causing encephalitis in a tribal population of Odisha in eastern India. Natl Med J India 28:185–187PubMed

Basak S, Mondal A, Polley S, Mukhopadhyay S, Chattopadhyay D (2007) Reviewing Chandipura: a vesiculovirus in human epidemics. Biosci Rep 27:275–298PubMedPubMedCentral

Rao NS, Wairagkar NS, Mohan MV, Khetan M, Somavathi S (2008) Brain stem encephalitis associated with Chandipura virus in Andhra Pradesh outbreak. J Trop Pediatr 54:25–30

Venkateswarlu CH, Arankalle VA (2009) Recombinant glycoprotein based vaccine for Chandipura virus infection. Vaccine 27:2845–2850PubMed

10.

Ghosh S, Basu A (2017) Neuropathogenesis by Chandipura virus: an acute encephalitis syndrome in India. Natl Med J India 30:21–25PubMed

11.

Kumar S, Arankalle VA (2010) Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis. PLoS One 5:1–13

12.

Roy A, Chakraborty P, Polley S, Chattopadhyay D, Roy S (2013) A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus—an emerging Rhabdovirus. Antivir Res 100:346–355PubMed

13.

Venkateswarlu CH, Arankalle VA (2010) Evaluation of the immunogenicity of a recombinant glycoprotein-based Chandipura vaccine in combination with commercially available DPT vaccine. Vaccine 28:1463–1467PubMed

14.

Jadi RS, Anakkathil SB, Barde PV, Arankalle VA, Mishra AC (2011) Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: vesiculovirus). Vaccine 29:4613–4617PubMed

15.

Kemper C, Atkinson JP (2007) T-cell regulation: with complements from innate immunity. Nat Rev Immunol 7:9–18PubMed

16.

Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5:981–986PubMed

17.

Blue CE, Spiller OB, Blackbourn DJ (2004) The relevance of complement to virus biology. Virology 319:176–184PubMed

18.

Gasque P (2004) Complement: a unique innate immune sensor for danger signals. Mol Immunol 41:1089–1098PubMed

19.

Johnson JB, Grant K, Parks GD (2009) The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 To evade complement-mediated neutralization. J Virol 83:7602–7611PubMedPubMedCentral

20.

Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058–1066PubMed

21.

Stahl PD, Ezekowitz RA (1998) The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50–55PubMed

22.

Lu J, Le Y (1998) Ficolins and the fibrinogen like domain. Immunobiology 199:190–199PubMed

23.

Pangburn MK, Schreiber RD, Müller-Eberhard HJ (1981) Formation of the initial C3 convertase of the alternative pathway: acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med 154:856–867PubMed

24.

Stoermer KA, Morrison TE (2011) Complement and viral pathogenesis. Virology 411:362–373PubMedPubMedCentral

25.

Biswas M, Johnson JB, Kumar SRP, Parks GD, Subbiaha E (2012) Incorporation of host complement regulatory proteins into newcastle disease virus enhances complement evasion. J Virol 86:12708PubMedPubMedCentral

26.

Balakrishnan A, Mishra AC (2008) Immune response during acute Chandipura viral infection in experimentally infected susceptible mice. Virol J 5:121PubMedPubMedCentral

27.

Balakrishnan A, Shahir P (2011) Immune regulation in Chandipura virus infection: characterization of CD4+ T regulatory cells from infected mice. Virol J 8:259

28.

Balakrishnan A, Shahir P (2012) Chandipura Virus infection in mice: the role of toll like receptor 4 in pathogenesis. BMC Infect Dis 12:125

29.

Balakrishnan A, Balasubramaniam GA, Shelke VN, Gunjikar R, Shewale P (2013) Neuro-invasion of Chandipura virus mediates pathogenesis in experimentally infected mice. Int J Clin Exp Pathol 6:1272–1281

30.

Roy S, Pavitrakar D, Gunjikar R, Ayachit VM, Bondre VP, Sapkal GN (2016) Monocytes and B cells support active replication of Chandipura virus. BMC Infect Dis 16:487PubMedPubMedCentral

31.

Beebe DP, Cooper NR (1981) Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126:1562–1568PubMed

32.

Reed JL, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497

33.

Johnson JB, Capraro GA, Parks GD (2008) Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses Simian virus 5 and Mumps virus. Virology 376:112–123PubMedPubMedCentral

34.

Shevach EM (2003) Chapter 13: Complement. Curr Protoc Immunol 58:13.0.1–13.0.4. https://doi.org/10.1002/0471142735.im1300s58 CrossRef

35.

Parasha D, Paingankar Mandar S, Kumar Satyendra, Gokhale Mangesh D, Sudeep AB, Shinde Sapana B, Arankalle VA (2013) Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus. PLoS Negl Trop Dis 7(9):e2405

36.

Des Prez RM, Bryan CS, Hawiger J, Colley DG (1975) Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-Ethylene glycol tetraacetic acid. Infect Immun 11:1235–1243PubMedPubMedCentral

37.

Kumar S, Jadi RS, Anakkathil SB, Tandale BV, Mishra AC, Arankalle VA (2008) Development and evaluation of a real-time one step Reverse-Transcriptase PCR for quantitation of Chandipura Virus. BMC Infect Dis 8:168PubMedPubMedCentral

38.

Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PVL (2009) Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Vaccine 27:2513–2522PubMed

39.

Kumar M, Anakkathil SB, Arankalle VA (2012) Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus. Vaccine 30:6142–6149PubMed

40.

Hammarlund E, Amanna IJ, Dubois ME, Barron A, Engelmann F (2012) A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus. PLoS One 7:e41707PubMedPubMedCentral

41.

Johnson JB, Aguilar HC, Lee B, Parks GD (2011) Interactions of human complement with virus particles containing the Nipah virus glycoproteins. J Virol 85:5940–5948PubMedPubMedCentral

42.

Ochsenbein AF, Pinschewer DD, Odermatt B, Carroll MC, Hengartner H, Zinkernagel RM (1999) Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 190:1165–1174PubMedPubMedCentral

43.

Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Stojdl D, Peng KW, Russell SJ (2014) Vesiculovirus neutralization by natural IgM and complement. J Virol 88:6148–6157PubMedPubMedCentral

44.

Hirsch RL, Winkelstein JA, Griffin DE (1980) The role of complement in viral infections III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol 124:2507–2510PubMed

45.

Shuang Hu, Kumar Dipu Mohan, Sax Chelsea, Schuler Clayton, Akkina Ramesh (2016) Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses. Virology 488:162–168

46.

Mills BJ, Beebe DP, Cooper NR (1979) Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV lipoprotein complexes in human serum and complement-dependent viral lysis. J Immunol 121:1549–1557

47.

Kerr MA (1980) The human complement system: assembly of the classical pathway C3 convertase. Biochem J 189:173–181PubMedPubMedCentral

48.

Sahu A, Lambris JD (2001) Structure and biology of complement C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35–48PubMed

49.

Harrison RA (2018) The properdin pathway: an “alternative activation pathway” or a “critical amplification loop” for C3 and C5 activation? Semin Immunopathol 40:15–35PubMed

50.

Pangburn MK, Müller-Eberhard HJ (1986) The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem J 235:723–730PubMedPubMedCentral

51.

Bexborn F, Andersson PO, Chen H, Nilsson B, Ekdahl KN (2008) The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol 45:2370–2379PubMed

52.

Nilsson B, Nilsson Ekdahl K (2012) The tick-over theory revisited: is C3 a contact-activated protein? Immunobiology 217:1106–1110PubMed

53.

Xue X, Wu J, Ricklin D, Forneris F, Di Crescenzio P, Schmidt CQ, Granneman J, Sharp TH, Lambris JD (2017) Gros P Regulator dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol 24:643–651PubMedPubMedCentral

54.

Thurman JM, Holers VM (2006) The central role of the alternative complement pathway in human disease. J Immunol 176:1305–1310PubMed

55.

Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004) The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 138:439–446PubMedPubMedCentral

56.

Banda NK, Takahashi K, Wood AK, Holers VM, Arend WP (2007) Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J Immunol 179:4101–4109PubMed

57.

Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I—molecular mechanisms of activation and regulation. Front Immunol 6:262PubMedPubMedCentral

58.

Friedman HM, Wang L, Pangburn MK, Lambris JD, Lubinski J (2000) Novel mechanism of antibody independent complement neutralization of Herpes Simplex virus type 1. J Immunol 165:4528–4536PubMed

59.

Bartholomew RM, Esser AF, Muller-Eberhard HJ (1978) Lysis of oncornaviruses by human serum Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med 147:844–853PubMed

60.

Cooper NR, Jensen FC, Welsh RM Jr, Oldstone MB (1976) MBA Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 44:970–984

61.

Mills BJ, Beebe DP, Cooper NR (1979) Antibody-independent neutralization of vesicular stomatitis virus by human complement II Formation of VSV lipoprotein complexes in human serum and complement-dependent viral lysis. J Immunol 123:2518PubMed

62.

Oldstone MBA, Cooper NR, Larson DL (1974) Formation and biologic role of polyoma virus-antibody complexes A critical role for complement. J Exp Med 1974(140):549–565

63.

Beebe DP, Cooper NR (1981) Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126:1562–1568PubMed

Titel: Alternative pathway of complement activation has a beneficial role against Chandipura virus infection
verfasst von: Pooja Gupta
Anuradha S. Tripathy
Publikationsdatum: 28.11.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Medical Microbiology and Immunology / Ausgabe 2/2020
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-019-00648-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Alternative pathway of complement activation has a beneficial role against Chandipura virus infection

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients

Functional characterization and evaluation of protective efficacy of EA752–862 monoclonal antibody against B. anthracis vegetative cell and spores

Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century

Toll like-receptor agonist Pam3Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56

Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection

Mouse adaptation of the H9N2 avian influenza virus causes the downregulation of genes related to innate immune responses and ubiquitin-mediated proteolysis in mice

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Update Innere Medizin